Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Micro Therapeutics' Thrombolytic Brush:

This article was originally published in Clinica

Executive Summary

US company Micro Therapeutics has received approval to market its over-the-wire Thrombolytic Brush for cleaning haemodialysis access grafts which regularly gets clogged with blood. The device contains a removable 0.035 inch guidewire system that allows the clinician to maintain continual access for the duration of the procedure. It is designed for rapid interventional clot disruption and dissolution by mixing urokinase, a thrombolytic drug, with the blood clot.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts